Podcast: Dietary Supplements – Navigating the Regulatory Maze – Diagnosing Health Care | Epstein Becker & Green
The U.S. Food and Drug Administration’s (FDA’s) broad definition of “misbranding” has created some industry confusion, while the Federal Trade Commission’s (FTC’s) updates to its Health...